Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes

References

• BanchereauJBriereFCauxCImmunobiology of dendritic cellsAnnu Rev Immunol20001876781110837075
   PubMed Web of Science ®Google Scholar
• SinhaPClementsVKBuntSKAlbeldaSMOstrand-RosenbergSCross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 responseJ Immunol2007179297798317617589
   PubMed Web of Science ®Google Scholar
• NagarajSGuptaKPisarevVAltered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNat Med200713782883517603493
   PubMed Web of Science ®Google Scholar
• GhiringhelliFPuigPERouxSTumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferationJ Exp Med2005202791992916186184
   PubMed Web of Science ®Google Scholar
• SharmaMDBabanBChandlerPPlasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJ Clin Invest200711792570258217710230
   PubMed Web of Science ®Google Scholar
• KuangDMZhaoQXuJYunJPWuCZhengLTumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathwaysJ Immunol200818153089309818713979
   PubMed Web of Science ®Google Scholar
• KryczekIWeiSZouLCutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cellsJ Immunol20061771404416785496
   PubMed Web of Science ®Google Scholar
• MellorALMunnDHIDO expression by dendritic cells: tolerance and tryptophan catabolismNat Rev Immunol200441076277415459668
   PubMed Web of Science ®Google Scholar
• WaitzRSolomonSBPetreENPotent induction of tumor immunity by combining tumor cryo-ablation with anti-CTLA-4 therapyCancer Res201272243043922108823
   PubMed Web of Science ®Google Scholar
• BraunKWiesslerMEhemannVTreatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistryDrug Des Devel Ther20092289301
   Google Scholar
• NierkensSden BrokMHRoelofsenTRoute of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in micePLoS One2009412e836820020049
   PubMed Web of Science ®Google Scholar
• HaenSPPereiraPLSalihHRRammenseeHGGouttefangeasCMore than just tumor destruction: immunomodulation by thermal ablation of cancerClin Dev Immunol2011201116025022242035
   PubMed Web of Science ®Google Scholar
• den BrokMHSutmullerRPNierkensSEfficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunityBr J Cancer200695789690516953240
   PubMed Web of Science ®Google Scholar
• den BrokMHSutmullerRPvan der VoortRIn situ tumor ablation creates an antigen source for the generation of antitumor immunityCancer Res200464114024402915173017
   PubMed Web of Science ®Google Scholar
• GallucciSLolkemaMMatzingerPNatural adjuvants: endogenous activators of dendritic cellsNat Med19995111249125510545990
   PubMed Web of Science ®Google Scholar
• ShiYRockKLCell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigensEur J Immunol200232115516211754356
   PubMed Web of Science ®Google Scholar
• SabelMSCryo-immunology: A review of the literature and proposed mechanisms for stimulatory versus suppressive immune responsesCryobiology200958111119007768
   PubMed Web of Science ®Google Scholar
• ChauxPFavreNMartinMMartinFTumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. International journal of cancerInt J Cancer19977246196249259401
   PubMed Web of Science ®Google Scholar
• ChattopadhyayGShevachEMAntigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanismJ Immunol2013191125875588424218453
   PubMed Web of Science ®Google Scholar
• VignaliDACollisonLWWorkmanCJHow regulatory T cells workNat Rev Immunol20088752353218566595
   PubMed Web of Science ®Google Scholar
• Acuner-OzbabacanESEnginBHGuven-MaiorovEThe structural network of Interleukin-10 and its implications in inflammation and cancerBMC Genomics201415Suppl 4S225056661
   PubMedGoogle Scholar
• GabrilovichDMechanisms and functional significance of tumour-induced dendritic-cell defectsNat Rev Immunol200441294195215573129
   PubMed Web of Science ®Google Scholar
• WangTNiuGKortylewskiMRegulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsNat Med2004101485414702634
   PubMed Web of Science ®Google Scholar
• BlochOCraneCAKaurRSafaeeMRutkowskiMJParsaATGliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophagesClin Cancer Res201319123165317523613317
   PubMed Web of Science ®Google Scholar
• LiMLiuJZhangSZCellular immunologic response to primary cryo-ablation of C6 gliomas in ratsTechnol Cancer Res Treat20111019510021214292
   PubMed Web of Science ®Google Scholar
• ZitvogelLKeppOSenovillaLMengerLChaputNKroemerGImmunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathwayClin Cancer Res201016123100310420421432
   PubMed Web of Science ®Google Scholar
• CurielTJTregs and rethinking cancer immunotherapyJ Clin Invest200711751167117417476346
   PubMed Web of Science ®Google Scholar
• WeiWZMorrisGPKongYCAnti-tumor immunity and autoimmunity: a balancing act of regulatory T cellsCancer Immunol Immunother2004532737814610619
   PubMed Web of Science ®Google Scholar
• GrauerOMNierkensSBenninkECD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivoInt J Cancer200712119510517315190
   PubMed Web of Science ®Google Scholar
• ZarogoulidisKZiogasEBoutsikouEImmunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized studyDrug Des Devel Ther20137611617
   PubMed Web of Science ®Google Scholar
• MaesWRosasGGVerbinnenBDC vaccination with anti-CD25 treatment leads to long-term immunity against experimental gliomaNeuro Oncol200911552954219336528
   PubMed Web of Science ®Google Scholar